Biomedical nanoparticle design: What we can learn from viruses
SM Figueroa, D Fleischmann, A Goepferich - Journal of Controlled Release, 2021 - Elsevier
Viruses are nanomaterials with a number of properties that surpass those of many synthetic
nanoparticles (NPs) for biomedical applications. They possess a rigorously ordered …
nanoparticles (NPs) for biomedical applications. They possess a rigorously ordered …
SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration
The post-infection of COVID-19 includes a myriad of neurologic symptoms including
neurodegeneration. Protein aggregation in brain can be considered as one of the important …
neurodegeneration. Protein aggregation in brain can be considered as one of the important …
Recent insights into viral infections as a trigger and accelerator in alzheimer's disease
L De Vlieger, RE Vandenbroucke, L Van Hoecke - Drug Discovery Today, 2022 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder for which only
symptomatic medication is available, except for the recently FDA-approved aducanumab …
symptomatic medication is available, except for the recently FDA-approved aducanumab …
[HTML][HTML] Natural compounds may contribute in preventing SARS-CoV-2 infection: a narrative review
ME Bizzoca, S Leuci, MD Mignogna, EL Muzio… - Food Science and …, 2022 - Elsevier
Coronavirus pandemic infection is the most important health issue worldwide. Coronavirus
disease 2019 is a contagious disease characterized by severe acute respiratory syndrome …
disease 2019 is a contagious disease characterized by severe acute respiratory syndrome …